151 related articles for article (PubMed ID: 29701699)
1. Simultaneous Determination of Decursin, Decursinol Angelate, Nodakenin, and Decursinol of
Kim SJ; Ko SM; Choi EJ; Ham SH; Kwon YD; Lee YB; Cho HY
Molecules; 2018 Apr; 23(5):. PubMed ID: 29701699
[TBL] [Abstract][Full Text] [Related]
2. Single oral dose pharmacokinetics of decursin, decursinol angelate, and decursinol in rats.
Li L; Zhang J; Xing C; Kim SH; Lü J
Planta Med; 2013 Mar; 79(3-4):275-80. PubMed ID: 23364885
[TBL] [Abstract][Full Text] [Related]
3. Quantitative determination of decursin, decursinol angelate, and decursinol in mouse plasma and tumor tissue using liquid-liquid extraction and HPLC.
Li L; Zhang J; Shaik AA; Zhang Y; Wang L; Xing C; Kim SH; Lü J
Planta Med; 2012 Feb; 78(3):252-9. PubMed ID: 22116603
[TBL] [Abstract][Full Text] [Related]
4. The simultaneous determination of coumarins in Angelica gigas root by high performance liquid chromatography-diode array detector coupled with electrospray ionization/mass spectrometry.
Ahn MJ; Lee MK; Kim YC; Sung SH
J Pharm Biomed Anal; 2008 Jan; 46(2):258-66. PubMed ID: 17997069
[TBL] [Abstract][Full Text] [Related]
5. Nanocomposites based on Soluplus and Angelica gigas Nakai extract fabricated by an electrohydrodynamic method for oral administration.
Lee JJ; Nam S; Park JH; Lee SY; Jeong JY; Lee JY; Kang WS; Yoon IS; Kim DD; Cho HJ
J Colloid Interface Sci; 2016 Dec; 484():146-154. PubMed ID: 27599383
[TBL] [Abstract][Full Text] [Related]
6. Anti-cancer and other bioactivities of Korean Angelica gigas Nakai (AGN) and its major pyranocoumarin compounds.
Zhang J; Li L; Jiang C; Xing C; Kim SH; Lü J
Anticancer Agents Med Chem; 2012 Dec; 12(10):1239-54. PubMed ID: 22583405
[TBL] [Abstract][Full Text] [Related]
7. Prostate Cancer Xenograft Inhibitory Activity and Pharmacokinetics of Decursinol, a Metabolite of Angelica gigas Pyranocoumarins, in Mouse Models.
Wu W; Tang SN; Zhang Y; Puppala M; Cooper TK; Xing C; Jiang C; Lü J
Am J Chin Med; 2017; 45(8):1773-1792. PubMed ID: 29121805
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acids incorporated colloidal systems for the delivery of Angelica gigas Nakai extract.
Lee JJ; Park JH; Lee JY; Jeong JY; Lee SY; Yoon IS; Kang WS; Kim DD; Cho HJ
Colloids Surf B Biointerfaces; 2016 Apr; 140():239-245. PubMed ID: 26764107
[TBL] [Abstract][Full Text] [Related]
9. Pyranocoumarin Tissue Distribution, Plasma Metabolome and Prostate Transcriptome Impacts of Sub-Chronic Exposure to Korean Angelica Supplement in Mice.
Zhang J; Li L; Tang S; Zhang Y; Markiewski M; Xing C; Jiang C; Lü J
Am J Chin Med; 2016; 44(2):321-53. PubMed ID: 27080944
[TBL] [Abstract][Full Text] [Related]
10. Single oral dose pharmacokinetics of decursin and decursinol angelate in healthy adult men and women.
Zhang J; Li L; Hale TW; Chee W; Xing C; Jiang C; Lü J
PLoS One; 2015; 10(2):e0114992. PubMed ID: 25695490
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 Isoforms in the Metabolism of Decursin and Decursinol Angelate from Korean Angelica.
Zhang J; Li L; Tang S; Hale TW; Xing C; Jiang C; Lü J
Am J Chin Med; 2015; 43(6):1211-30. PubMed ID: 26394652
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial coumarins from Angelica gigas roots.
Lee S; Shin DS; Kim JS; Oh KB; Kang SS
Arch Pharm Res; 2003 Jun; 26(6):449-52. PubMed ID: 12877552
[TBL] [Abstract][Full Text] [Related]
13. Anti-Inflammatory Effect of Angelica gigas via Heme Oxygenase (HO)-1 Expression.
Cho JH; Kwon JE; Cho Y; Kim I; Kang SC
Nutrients; 2015 Jun; 7(6):4862-74. PubMed ID: 26083119
[TBL] [Abstract][Full Text] [Related]
14. In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin.
Lee HJ; Lee HJ; Lee EO; Lee JH; Lee KS; Kim KH; Kim SH; Lü J
Am J Chin Med; 2009; 37(1):127-42. PubMed ID: 19222117
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of an ultra-performance convergence chromatography method for the quality control of Angelica gigas Nakai.
Kim HS; Chun JM; Kwon BI; Lee AR; Kim HK; Lee AY
J Sep Sci; 2016 Oct; 39(20):4035-4041. PubMed ID: 27510737
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor activities of decursinol angelate and decursin from Angelica gigas.
Lee S; Lee YS; Jung SH; Shin KH; Kim BK; Kang SS
Arch Pharm Res; 2003 Sep; 26(9):727-30. PubMed ID: 14560921
[TBL] [Abstract][Full Text] [Related]
17. Absorption, distribution, metabolism, and excretion of decursin and decursinol angelate from Angelica gigas Nakai.
Kim KM; Kim MJ; Kang JS
J Microbiol Biotechnol; 2009 Dec; 19(12):1569-72. PubMed ID: 20075620
[TBL] [Abstract][Full Text] [Related]
18. Platelet anti-aggregatory effects of coumarins from the roots of Angelica genuflexa and A. gigas.
Lee YY; Lee S; Jin JL; Yun-Choi HS
Arch Pharm Res; 2003 Sep; 26(9):723-6. PubMed ID: 14560920
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of polymer matrix-free nanocomposites based on Angelica gigas Nakai extract and their application to breast cancer therapy.
Lee SY; Lee JJ; Nam S; Kang WS; Yoon IS; Cho HJ
Colloids Surf B Biointerfaces; 2017 Nov; 159():781-790. PubMed ID: 28886514
[TBL] [Abstract][Full Text] [Related]
20. Biopharmaceutical characterization of decursin and their derivatives for drug discovery.
Mahat B; Chae JW; Baek IH; Song GY; Song JS; Ma JY; Kwon KI
Drug Dev Ind Pharm; 2013 Oct; 39(10):1523-30. PubMed ID: 23003006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
